日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-α inhibitor therapy and literature review

免疫失调患者肝脾T细胞淋巴瘤的发生：一项对7例未接受肿瘤坏死因子-α抑制剂治疗的患者的研究及文献综述

期刊:Annals of Diagnostic Pathology
影响因子:1.4
doi:10.1016/j.anndiagpath.2016.10.005
Yabe, Mariko; Medeiros, L Jeffrey; Daneshbod, Yahya; Davanlou, Masoud; Bueso-Ramos, Carlos E; Moran, Elisa J; Young, Ken H; Miranda, Roberto N
肿瘤
T细胞
肿瘤免疫
淋巴瘤
T细胞
细胞生物学
免疫/内分泌
发表日期：2017
文献求助 收藏

Effect of Etomidate Versus Combination of Propofol-Ketamine and Thiopental-Ketamine on Hemodynamic Response to Laryngoscopy and Intubation: A Randomized Double Blind Clinical Trial

依托咪酯与丙泊酚-氯胺酮联合用药和硫喷妥钠-氯胺酮联合用药对喉镜检查和气管插管时血流动力学反应的影响：一项随机双盲临床试验

期刊:Anesthesiology and Pain Medicine
影响因子:
doi:10.5812/aapm.30071
Gholipour Baradari, Afshin; Firouzian, Abolfazl; Zamani Kiasari, Alieh; Aarabi, Mohsen; Emadi, Seyed Abdollah; Davanlou, Ali; Motamed, Nima; Yousefi Abdolmaleki, Ensieh
发表日期：2016
文献求助 收藏

Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents

骨髓增生异常综合征中PD-L1、PD-L2、PD-1和CTLA4的表达会因低甲基化药物治疗而增强。

期刊:Leukemia
影响因子:13.4
doi:10.1038/leu.2013.355
Yang, H; Bueso-Ramos, C; DiNardo, C; Estecio, M R; Davanlou, M; Geng, Q-R; Fang, Z; Nguyen, M; Pierce, S; Wei, Y; Parmar, S; Cortes, J; Kantarjian, H; Garcia-Manero, G
PD-L1
表观遗传
PD-1
CTLA4
发表日期：2014
文献求助 收藏